Revolution Medicines (RVMD) says FDA allows expanded access for daraxonrasib in patients with previously treated metastatic pancreatic cancer
Revolution Medicines' announcement regarding the FDA's allowance for expanded access to daraxonrasib represents a significant positive development in their pipeline, particularly for patients with metastatic pancreatic cancer.
Contrary to the White House's baseless claims, there are no signs that Iran is running out of storage space, Tasnim reports
Anthropic looks to give more companies and organizations access to its powerful new Claude Mythos model, including in Japan, but faces opposition from the US, via Nikkei
Revolution Medicines (RVMD) says FDA allows expanded access for daraxonrasib in patients with previously treated metastatic pancreatic cancer
US Treasury Secretary Bessent says US has complete control of the Strait of Hormuz and blockade will continue until there is pre-February 27th Freedom of Navigation, via X in message to Iran leadership
Ares (ARES) CEO says demand has remained consistent despite recent market noise, seeing investors lean in; continue to exceed fundraising targets in most of our flagship fundraisers
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This could enhance their market positioning and potentially drive interest from investors and analysts, particularly if it aligns with favorable patient outcomes or further regulatory progress. Watch for any follow-up on efficacy or uptake in clinical settings, as these will be key indicators moving forward.
Related headlines
- Merck (MRK) veteran and psychedelics developer tapped for top FDA job18 hours ago
- FDA notes FI recalls dog supplements due to possible salmonella contamination21 hours ago
- US EQUITY OPEN: Indices in the red as US/Iran tensions escalate 1 hour ago
- US Quarterly Services Survey (Q2 2026): +3% to USD 6,418.7bln54 min ago
- DoJ confirms it issues second request for Fox (FOX) and Roku (ROKU) merger with closing expected in H1 '27 1 hour ago
- Newsquawk Daily US Equity Opening News: DOW weighs exit from $20b Saudi chemicals venture; GOOG to invest $15bln in Finnish AI infrastructure2 hours ago
- Gap (GAP) hires Jamie Drew as its new head of strategic partnerships and growth, Business Insider reports2 hours ago
- US BROKER MOVES: TMO upgraded at UBS; VMC downgraded at Wells Fargo2 hours ago
- Analog Devices (ADI) and Alif Semiconductor today announced a definitive agreement under which ADI will acquire Alif in an all-cash transaction for USD 1.35bln2 hours ago
- Sam Altman privately told a group of GOP economists he does NOT support having the government own shares in OpenAI, reports Washington Sun3 hours ago
- Dow (DOW) reportedly weighs exit from USD 20bln Saudi chemicals venture3 hours ago
- Amazon (AMZN) plans to issue multiple series of sterling-denominated notes3 hours ago
- Baker Hughes (BKR) guides FY26 revenue USD 28.5-30.3bln (prev. USD 26.7-28.1bln) and adj. EBITDA USD 4.9-5.5bln (prev. USD 4.6-5.1bln), according to SEC filing4 hours ago
- Sysco (SYY) reaffirms its FY27 guidance and raises its mid-term targets4 hours ago
- Google (GOOG) is to invest a minimum of EUR 13bln in Finland’s AI infrastructure in 2027-28, according to Finnish broadcaster YLE8 hours ago
- OpenAI offers AI for chip design and touts cost advantage over open source14 hours ago
- US Department of Justice plans closer scrutiny of Fox's (FOXA) USD 22bln Roku (ROKU) deal, according to Semafor15 hours ago
- Broadcom (AVGO) CEO says co. can lock in chip supply for 2027 and it is in the process of locking in 2028 supply 19 hours ago
- Meta (META) introduces Muse AI agent; rolling out in the US on iOS, Android and Muse.AI, coming soon to AI glasses19 hours ago
- Trump admin criticizes Ford (F) partnerships with Chinese companies, according to reports, citing a letter19 hours ago
The whole workspace, free to try.
Try it free